Category: PSYCH STOCK NEWS

Lobe Sciences (GTSIF) Provides Corporate Update to Investors and Stakeholders

CSE symbol (LOBE). LIVE QUOTE Vancouver, British Columbia–(Newsfile Corp. – September 13, 2021) – Lobe Sciences Ltd. (CSE:...

Ketamine One (KONEF) Signs LOI for Two Ketamine Infusion Clinics in Texas

The Arrangement Bolsters the Company’s Proposed Network of Six Clinics in the United States VANCOUVER, British Columbia, Sept. 08, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One”...

Mydecine Innovations Group (MYCOF) Announces Smoking Cessation Clinical Trial

NEO Exchange (MYCO) Mydecine Innovations Group Announces MYCO-001 Seamless Phase 2/3 Smoking Cessation Clinical Trial Dr. Matthew Johnson will...

Ehave (EHVVF) Announces Update On Ehave Medical App With The Launch Of Covid Vaccine Passport Going Live Shortly

Ehave's Covid Passport provides small businesses a tool to verify Covid-19 vaccination, and a suite of products to improve both the mental and overall health of individuals.

Huge News at Ehave Inc.(EHVVF), our Favorite Psychedelic.

We just finished compiling the 2021 Psychedelic Investor Guide and reviewed 44 companies – in all shapes and sizes. Excluding Johnson & Johnson at $420 billion, the market caps range from as...

Mycotopia Therapies (TPIA) Signs Agreement With Havn Life Sciences (HAVLF) For Purchase of Psilocybin SPP

Both companies to follow necessary protocols to allow for export of naturally-derived psilocybin from Canada and import into the US MIAMI, Aug. 25, 2021 (GLOBE NEWSWIRE) --...

Video: Business TV News

https://youtu.be/hcAPjuov7wo Featured companies: Entheon Biomedical Corp. (CSE: ENBI, OTCQB: ENTBF)Researching and developing DMT, one of the most powerful of its kind in...

Compass Pathways (CMPS) Reports 2Q and Business Highlights.

"Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. This is the largest trial ever conducted in...
Most Popular

Interview: MAPS Founder Rick Doblin and Clearmind Medicine (CMND) CEO, Adi Zuloff-Shani.

INTRO VIDEO https://youtu.be/-RQikn6O3qw?si=o_IBy9yTlmfNNvky Join Clearmind Medicine CEO, Adi Zuloff-Shani,...

1000 Days Without Alcohol: Here’s What Happened

No..we didn't give up drinking - at least not yet. But we RUMinate about it from time to time. At a dinner...

Startup Ketamine Clinic ‘Being Health’ Raises $5.4 Million

This startup is opening a mental health clinic that offers ketamine therapy. BusinessInsider got an exclusive look at the pitch deck it...